Risk factors for the development and severity of interstitial lung disease associated with EGFR tyrosine kinase inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
Not Applicable
- Conditions
- EGFR tyrosine kinase inhibitor-associated interstitial lung disease
- Registration Number
- JPRN-UMIN000050523
- Lead Sponsor
- Showa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Pediatric patients under 18 years of age Adult patients with histopathologically diagnosed small-cell lung cancer
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Risk factors for the severity of interstitial lung disease
- Secondary Outcome Measures
Name Time Method Risk factors for the development of interstitial lung disease